| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |